← Back
Data updated: Mar 29, 2026
ABBOTT
Infectious DiseaseDermatologyNeurology
Big Pharma
ABBOTT is a major pharmaceutical company focused on Infectious Disease, Dermatology, Neurology.
1959
Since
92
Drugs
-
Trials
196
Approved (2yr)
Key Drugs
No active drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Competitive Matchups Pro
Loading...
Loading...
Recent Activity
METRONIDAZOLE 2026-02-17
Labeling
METRONIDAZOLE 2026-02-17
Labeling
METRONIDAZOLE 2026-02-13
CHLORPROMAZINE HYDROCHLORIDE 2026-01-26
NALBUPHINE HYDROCHLORIDE 2025-12-22
Labeling
NALBUPHINE HYDROCHLORIDE 2025-12-22
Labeling
MEPERIDINE HYDROCHLORIDE 2025-12-22
Labeling
MEPERIDINE HYDROCHLORIDE 2025-12-22
Labeling
SEC Filings
Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Infectious Disease 33%
2 drugs
Dermatology 17%
1 drugs
Neurology 17%
1 drugs
Metabolic 17%
1 drugs
Respiratory 17%
0 drugs Phase 3: 1 Phase 2: 1
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Competitors by Therapeutic Area
PHARMACIA AND UPJOHN big-pharma
Dermatology, Infectious Disease, Respiratory, Metabolic
LEDERLE big-pharma
Infectious Disease, Neurology, Dermatology, Respiratory
GSK big-pharma
Infectious Disease, Respiratory, Neurology
Sanofi big-pharma
Metabolic, Infectious Disease, Respiratory
Eli Lilly big-pharma
Metabolic, Neurology, Dermatology
Active (8)
Discontinued (84)
METRONIDAZOLE CHLORPROMAZINE HYDROCHLORIDE MEPERIDINE HYDROCHLORIDE FENTANYL CITRATE NALBUPHINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE AMIKACIN SULFATE PROMETHAZINE HYDROCHLORIDE TETRACYCLINE HYDROCHLORIDE CHLORTHALIDONE DOPAMINE HYDROCHLORIDE GENTAMICIN SULFATE NORVIR DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER A-METHAPRED DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER TPN ELECTROLYTES IN PLASTIC CONTAINER LIDOCAINE HYDROCHLORIDE 0.2% IN DEXTROSE 5% IN PLASTIC CONTAINER NITROPRESS DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINER MERIDIA HYTRIN VICODIN A-HYDROCORT AMINOSYN II 5% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER AMINOSYN II 3.5% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER AMINOSYN II 4.25% W/ ELECTROLYTES IN DEXTROSE 25% W/ CALCIUM IN PLASTIC CONTAINER AMINOSYN II 4.25% W/ ELECTROLYTES IN DEXTROSE 20% W/ CALCIUM IN PLASTIC CONTAINER PROSOM CYLERT AMINOSYN II 4.25% IN DEXTROSE 25% IN PLASTIC CONTAINER AMINOSYN II 3.5% IN DEXTROSE 5% IN PLASTIC CONTAINER AMINOSYN II 5% IN DEXTROSE 25% IN PLASTIC CONTAINER AMINOSYN II 3.5% IN DEXTROSE 25% IN PLASTIC CONTAINER AMINOSYN II 4.25% IN DEXTROSE 20% IN PLASTIC CONTAINER AMINOSYN II 4.25% IN DEXTROSE 10% IN PLASTIC CONTAINER AMINOSYN II 4.25% M IN DEXTROSE 10% IN PLASTIC CONTAINER AMINOSYN II 3.5% M IN DEXTROSE 5% IN PLASTIC CONTAINER AMINOSYN II 4.25% W/ ELECT AND ADJUSTED PHOSPHATE IN DEXTROSE 10% IN PLASTIC CONTAINER CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER PENTHRANE PENTOTHAL ENFLURANE CALCIUM GLUCEPTATE LIDOCAINE HYDROCHLORIDE W/ EPINEPHRINE ENDURONYL ENDURONYL FORTE LOPURIN
+34 more
Company Info
- First Approval
- 1959-09-23
- Latest
- 2010-08-04
- Applications
- 114
FDA Sponsor Names
ABBOTTABBOTT LABS